ATE174798T1 - Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation - Google Patents

Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Info

Publication number
ATE174798T1
ATE174798T1 AT92900114T AT92900114T ATE174798T1 AT E174798 T1 ATE174798 T1 AT E174798T1 AT 92900114 T AT92900114 T AT 92900114T AT 92900114 T AT92900114 T AT 92900114T AT E174798 T1 ATE174798 T1 AT E174798T1
Authority
AT
Austria
Prior art keywords
treatment
cell proliferation
compositions
preparation
proliferation diseases
Prior art date
Application number
AT92900114T
Other languages
English (en)
Inventor
Lawrence M Blatt
Milton W Taylor
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE174798T1 publication Critical patent/ATE174798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92900114T 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation ATE174798T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15

Publications (1)

Publication Number Publication Date
ATE174798T1 true ATE174798T1 (de) 1999-01-15

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900114T ATE174798T1 (de) 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Country Status (17)

Country Link
EP (1) EP0553294B1 (de)
JP (1) JP3496937B2 (de)
CN (1) CN1053117C (de)
AT (1) ATE174798T1 (de)
AU (1) AU660633B2 (de)
CA (1) CA2094275C (de)
DE (1) DE69130679T2 (de)
DK (1) DK0553294T3 (de)
ES (1) ES2128348T3 (de)
HK (1) HK1010340A1 (de)
IE (1) IE913656A1 (de)
IL (1) IL99778A (de)
NO (1) NO931413D0 (de)
NZ (1) NZ240264A (de)
PT (1) PT99265B (de)
SG (1) SG52537A1 (de)
WO (1) WO1992006707A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
RU2006145020A (ru) 2004-05-19 2008-06-27 Максиджен, Инк. (Us) Полипептиды и конъюгаты интерферона-альфа
KR101329878B1 (ko) * 2005-03-09 2013-11-22 광웬 위 재조합 슈퍼 화합물 인터페론의 용도
WO2007044083A2 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
AU9023591A (en) 1992-05-20
CA2094275A1 (en) 1992-04-18
EP0553294A1 (de) 1993-08-04
IL99778A (en) 1996-11-14
NO931413L (no) 1993-04-16
WO1992006707A1 (en) 1992-04-30
DE69130679T2 (de) 1999-05-06
AU660633B2 (en) 1995-07-06
NO931413D0 (no) 1993-04-16
CA2094275C (en) 2003-06-03
SG52537A1 (en) 1998-09-28
IE913656A1 (en) 1992-04-22
PT99265A (pt) 1992-08-31
NZ240264A (en) 1997-07-27
JPH06502426A (ja) 1994-03-17
DK0553294T3 (da) 1999-08-23
CN1053117C (zh) 2000-06-07
ES2128348T3 (es) 1999-05-16
EP0553294A4 (en) 1994-11-23
EP0553294B1 (de) 1998-12-23
DE69130679D1 (de) 1999-02-04
HK1010340A1 (en) 1999-06-17
PT99265B (pt) 1999-04-30
JP3496937B2 (ja) 2004-02-16
IL99778A0 (en) 1993-02-21
CN1064018A (zh) 1992-09-02

Similar Documents

Publication Publication Date Title
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
DE69034076D1 (de) Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
DE59107405D1 (de) Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
ATE81587T1 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time